Suchergebnisse - "Munro, Trent"

PubPharm (99)

1

Harnessing metabolic plasticity in CHO cells for enhanced perfusion cultivation

enthalten in: Biotechnology and bioengineering | 2024

von Nöbel, M. | Barry, C. | MacDonald, M. | +7

2

Broad immunity to SARS-CoV-2 variants of concern mediated by a SARS-CoV-2 receptor-binding domain protein vaccine

enthalten in: bioRxiv.org | 2024

von Deliyannis, G. | Gherardin, N. | Wong, C. | +38

3

Anticipatory regulation for pandemic responses : are we there yet?

enthalten in: Trends in biotechnology | 2024

von Oyola-Lozada, M. | Pregelj, L. | Jenkins, A. | +3

4

Are Manufacturing Patents to Blame for Biosimilar Market Launch Delays?

enthalten in: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | 2024

von Williamson, R. | Munro, T. | Ascher, D. | +2

5

Amino acid degradation pathway inhibitory by-products trigger apoptosis in CHO cells

enthalten in: Biotechnology journal | 2024

von Martínez, V. | Rodriguez, K. | McCubbin, T. | +6

6

Amino acid degradation pathway inhibitory by‐products trigger apoptosis in CHO cells

enthalten in: Biotechnology Journal | 2024

von Martínez, V. | Rodriguez, K. | McCubbin, T. | +6

7

Harnessing metabolic plasticity in CHO cells for enhanced perfusion cultivation

enthalten in: Biotechnology and Bioengineering | 2024

von Nöbel, M. | Barry, C. | MacDonald, M. | +7

8

An alpaca-derived nanobody recognizes a unique conserved epitope and retains potent activity against the SARS-CoV-2 omicron variant

enthalten in: bioRxiv.org | 2023

von Modhiran, N. | Lauer, S. | Amarilla, A. | +35

9

SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike-ACE2 receptor interaction

enthalten in: bioRxiv.org | 2023

von Albornoz, E. | Amarilla, A. | Modhiran, N. | +26

10

Long-term safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2 in adults aged 18-55 years or ≥56 years : 12-month results from a randomised, double-blind, placebo-controlled, phase 1 trial

enthalten in: EBioMedicine | 2023

von Chappell, K. | Mordant, F. | Amarilla, A. | +20

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]